New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 18, 2012
12:11 EDTIBM, ILMN, APH, CREE, TXT, URI, STX, HAL, YHOO, INTC, RHHBYOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday, as disappointment with the reports of two blue chip technology companies weighed on the market. Stock futures were slightly lower during the pre-market trading session, leading to a lower open for the broader market. The averages have struggled since the opening bell, with little in the way of economic data to distract investors from the latest round of earnings reports... ECONOMIC EVENTS: Domestically, the Mortgage Bankers Association reported mortgage applications were up 6.9% from a week earlier, driven by refinancing. Crude oil inventories grew more than expected, while gasoline and distillates inventories shrank more than analysts forecast... COMPANY NEWS: IBM (IBM), Intel (INTC) and Yahoo (YHOO) all reported earnings after the close yesterday that beat consensus expectations, but only Yahoo shares rallied following the announcements. The declines in IBM, which saw its revenues miss expectations and its shares fall 2.5%, and Intel, down 2% after its gross margins were worse than last quarter, weighed heavily on the Dow. In contrast, Yahoo gained 3% as its revenue grew for the first time since Q3 of 2008, as noted by Piper Jaffray... Among other companies reporting earnings, advancers included Halliburton (HAL), Seagate (STX) and United Rentals (URI); decliners included Textron (TXT), Cree (CREE) and Amphenol (APH)... MAJOR MOVERS: Among the notable gainers were Catalyst Health Solutions (CHSI), up 31%, and SXC Health Solutions (SXCI), up 7.5%, as both stocks benefited from plans to merge the companies in a cash and stock transaction that implies a purchase price of $81.02 per Catalyst share. Also higher were shares of THQ Inc. (THQI), up 36%, after the company raised its expectations for Q4 on strong sales of its "Saints Row" game. Noteworthy losers included Genworth (GNW), down 21%, after announcing it would delay the IPO of its Australian mortgage insurance business until early 2013, and Chesapeake Energy (CHK), down 10%, after Reuters reported that its CEO took out as much as $1.1B in unreported loans over the last three years which could raise the possibility of conflicts of interest. Also lower were shares of Illumina (ILMN), down 2.5%, after Roche (RHHBY) decided not to extend its $51 cash tender offer for the company... INDICES: Near noon, the Dow was down 47.34, or 0.36%, to 13,068.20; the Nasdaq was down 10.72, or 0.35%, to 3,032.10; and the S&P 500 was down 3.79, or 0.27%, to 1,386.99.
News For IBM;INTC;YHOO;HAL;STX;URI;TXT;CREE;APH;ILMN;RHHBY From The Last 14 Days
Check below for free stories on IBM;INTC;YHOO;HAL;STX;URI;TXT;CREE;APH;ILMN;RHHBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
August 20, 2014
12:11 EDTYHOOStocks with call strike movement; UAL YHOO
United Continental (UAL) December 55 call option implied volatility decreased 3% to 42, Yahoo (YHOO) November 45 call option implied volatility increased 2% to 42 according to IVolatility.
11:49 EDTYHOOBofA/Merrill telecom services analysts hold an analyst/industry conference call
Analysts discuss the upcoming IPO of Alibaba, which is expected to launch early September 2014, on an Analyst/Industry conference call to be held on August 21 at 8 am.
10:04 EDTILMNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:18 EDTILMNIllumina upgraded to Outperform from Neutral at Wedbush
Subscribe for More Information
August 19, 2014
11:32 EDTILMNLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
11:05 EDTIBMImperva seen as takeover candidate under new CEO
Subscribe for More Information
08:42 EDTIBMImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.
05:48 EDTYHOOStocks with implied volatility movement; AEO YHOO
Subscribe for More Information
August 18, 2014
10:57 EDTCREEOptions with decreasing implied volatility
Subscribe for More Information
10:29 EDTINTCGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
08:04 EDTINTCSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
06:23 EDTYHOOYahoo acquires Israel-based ad startup ClarityRay, terms not disclosed
Israel-based ad startup ClarityRay announced on its website that it has been acquired by Yahoo. Terms of the deal have not been disclosed. Reference Link
06:06 EDTCREECree implied volatility of 28 at lower end of index mean range
Subscribe for More Information
August 17, 2014
13:40 EDTRHHBYChugai makes statement denying media reports on Roche deal
Subscribe for More Information
August 15, 2014
16:10 EDTIBMIBM issues statement on U.S. regulatory approval of x86 server sale to Lenovo
Subscribe for More Information
11:28 EDTRHHBYRoche in talks on $10B deal to buy remainder of Chugai, Bloomberg reports
Roche is in talks to purchase the 38% stake of Chugai Pharmaceutical that it doesn't already own, according to Bloomberg, citing people familiar with the matter. The potential deal is valued at approximately $10B. Though no financial decision has been made, the deal may be announced as early as next week, the sources added. Reference Link
11:02 EDTRHHBYRoche in talk on $10B deal to buy remainder of Chugai, Bloomberg says
Subscribe for More Information
06:24 EDTYHOOYahoo introduces Yahoo Stores
Subscribe for More Information
06:23 EDTINTCIntel teaming with SMS Audio for biometric earbuds, WSJ reports
Subscribe for More Information
06:12 EDTRHHBYGilead announced favorable ruling in arbitration against Roche
Gilead (GILD) announced that an arbitration panel determined that Roche (RHHBY) failed to establish any of their claims and ruled in favor of Gilead. As a result, Roche is not entitled to any damages or other relief. In March 2013, Roche initiated an arbitration against Gilead and Pharmasset, predecessor to Gilead Pharmasset, regarding a 2004 collaboration agreement between Roche and Pharmasset. In the arbitration demand, Roche asserted that it had an exclusive license to sofosbuvir pursuant to the collaboration agreement because sofosbuvir, a prodrug of a uridine monophosphate analog, is allegedly a prodrug of PSI-6130, a cytidine analog. Roche further claimed that, because it had exclusive rights to sofosbuvir, it also had an exclusive license to a patent covering sofosbuvir, and that we infringed that patent by selling and offering for sale products containing sofosbuvir.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use